Reimbursement at the ingredient level.
RemitAxiom is being designed to connect ingredient-level compound information with adjudication, coverage and reimbursement intelligence — so compound payments can be understood, not guessed at.
From compound to outcome.
A compound prescription moves through ingredients, a PBM, a plan and adjudication before a final outcome. RemitAxiom is designed to make each stage legible.
RemitAxiom is being designed to connect ingredient-level compound information with adjudication, coverage and reimbursement intelligence.
Rejection patterns, made legible.
When similar compounds are rejected for the same reason, RemitAxiom is designed to surface the pattern and the affected value — so it can be investigated rather than re-guessed.
Compound — Synthetic
REJECTION PATTERN DETECTED
73
Similar transactions
$8,417
Affected
Understanding a rejection does not guarantee coverage or reimbursement for a compounded drug. Compounding reimbursement depends on the plan, the PBM, applicable policy and medical necessity.
Designed to inform — not to promise coverage.
RemitAxiom's compound intelligence is intended to make the adjudication and reimbursement picture visible. It does not obtain coverage for compounded drugs, and coverage is never guaranteed.
No feature or demonstration on this site promises that compounded medications will be covered or reimbursed. Coverage decisions remain with the plan, the PBM and applicable policy.
Start with your data.
Bring your own exports. See what should have paid — with evidence.